Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes. [electronic resource]

By:

Yamagishi, Sho-Ichi

Contributor(s):

Matsui, Takanori
Ueda, Shin-Ichiro
Nakamura, Kazuo
Imaizumi, Tsutomu

Producer: 20070921Description: 236-40 p. digitalISSN:

1871-5257

Subject(s):

Cardiovascular Diseases -- etiology
Diabetes Mellitus -- drug therapy
Endothelium, Vascular -- metabolism
Glycation End Products, Advanced -- metabolism
Humans
Hypoglycemic Agents -- pharmacology

Online resources:

Available from publisher's website

In: Cardiovascular & hematological agents in medicinal chemistry vol. 5

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

There are no comments on this title.

Browse results Close

Back to results

1 PEDF mediates pathological neovascularization by regulating macrophage recruitment and polarization in the mouse model of oxygen-induced retinopathy.
by Gao, Sha
2 Neutralization of Bombina variegata peptide 8 suppresses retinal neovascularization in two different murine models: The oxygen-induced retinopathy model and the rhodopsin promoter/VEGF transgenic mouse model.
by Yao, Yiyun
3 Identification of different macrophage subpopulations with distinct activities in a mouse model of oxygen-induced retinopathy.
by Zhu, Yanji
4 Neutralization of IL-23 depresses experimental ocular neovascularization.
by Cai, Yujuan
5 Inhibition of integrin α5β1 ameliorates VEGF-induced retinal neovascularization and leakage by suppressing NLRP3 inflammasome signaling in a mouse model.
by Sui, Ailing
6 ATN-161 as an Integrin α5β1 Antagonist Depresses Ocular Neovascularization by Promoting New Vascular Endothelial Cell Apoptosis.
by Sui, Ailing
7 Endocan Blockade Suppresses Experimental Ocular Neovascularization in Mice.
by Su, Ting
8 Interleukin-17A neutralization alleviated ocular neovascularization by promoting M2 and mitigating M1 macrophage polarization.
by Zhu, Yanji

Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes.

APA

Yamagishi S., Matsui T., Ueda S., Nakamura K. & Imaizumi T. (20070921). Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes. : Cardiovascular & hematological agents in medicinal chemistry.

Chicago

Yamagishi Sho-Ichi, Matsui Takanori, Ueda Shin-Ichiro, Nakamura Kazuo and Imaizumi Tsutomu. 20070921. Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes. : Cardiovascular & hematological agents in medicinal chemistry.

Harvard

Yamagishi S., Matsui T., Ueda S., Nakamura K. and Imaizumi T. (20070921). Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes. : Cardiovascular & hematological agents in medicinal chemistry.

MLA

Yamagishi Sho-Ichi, Matsui Takanori, Ueda Shin-Ichiro, Nakamura Kazuo and Imaizumi Tsutomu. Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes. : Cardiovascular & hematological agents in medicinal chemistry. 20070921.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC